MedPath

鲁南贝特制药有限公司

Ownership
-
Established
2003-12-16
Employees
-
Market Cap
-
Website
https://lunan.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

146

NMPA:146

Drug Approvals

Choline Fenofibrate Sustained-release Capsules

Product Name
非诺贝特酸胆碱缓释胶囊
Approval Number
国药准字H20249525
Approval Date
Dec 1, 2024
NMPA

Choline Fenofibrate Sustained-release Capsules

Product Name
非诺贝特酸胆碱缓释胶囊
Approval Number
国药准字H20249524
Approval Date
Dec 1, 2024
NMPA

Minoxidil Liniment

Product Name
米诺地尔搽剂
Approval Number
国药准字H20244460
Approval Date
Jul 16, 2024
NMPA

Valsartan Tablets

Product Name
缬沙坦片
Approval Number
国药准字H20244307
Approval Date
Jun 28, 2024
NMPA

Minoxidil Liniment

Product Name
米诺地尔搽剂
Approval Number
国药准字H20243099
Approval Date
Jan 30, 2024
NMPA

Tirofiban Hydrochloride and Sodium Chloride Injection

Product Name
盐酸替罗非班氯化钠注射液
Approval Number
国药准字H20173032
Approval Date
Aug 23, 2023
NMPA

Omeprazole and Sodium Bicarbonate Capsules(Ⅱ)

Product Name
奥美拉唑碳酸氢钠胶囊(Ⅱ)
Approval Number
国药准字H20233987
Approval Date
Aug 1, 2023
NMPA

Tirofiban Hydrochloride

Product Name
盐酸替罗非班
Approval Number
国药准字H20090225
Approval Date
Jul 25, 2023
NMPA

Tirofiban Hydrochloride and Sodium Chloride Injection

Product Name
盐酸替罗非班氯化钠注射液
Approval Number
国药准字H20173030
Approval Date
Jul 25, 2023
NMPA

Tirofiban Hydrochloride Concentrated Solution for Injection

Product Name
盐酸替罗非班注射用浓溶液
Approval Number
国药准字H20090328
Approval Date
Jul 25, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 15
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.